Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR)
CUSIP: 471871202
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Voting Common Stock, par value $0.0001 per share
- Shares outstanding
- 28,086,431
- Total 13F shares
- 14,557,013
- Share change
- +1,599,050
- Total reported value
- $329,580,756
- Put/Call ratio
- 23%
- Price per share
- $22.70
- Number of holders
- 67
- Value change
- +$34,893,415
- Number of buys
- 41
- Number of sells
- 27
Quarterly Holders Quick Answers
What is CUSIP 471871202?
CUSIP 471871202 identifies JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 471871202:
Top shareholders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Velan Capital Investment Management LP |
13F
3/4/5
|
Company · 10%+ Owner |
5.2%
|
1,471,904
|
$42,097,193 | — | 31 Mar 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
4.2%
|
1,187,096
|
$34,853,139 | — | 31 Mar 2024 | |
| Carlyle Group Inc. |
13F
3/4/5
|
Company · Former 10% Owner |
3.8%
|
1,066,189
|
$31,303,309 | — | 31 Mar 2024 | |
| Qiming U.S. Ventures Management, LLC |
13F
|
Company |
3.3%
|
928,964
|
$27,274,383 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
2.7%
|
760,000
|
$22,313,600 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.6%
|
722,074
|
$21,200,093 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.2%
|
612,745
|
$17,990,193 | — | 31 Mar 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
1.9%
|
525,000
|
$15,414,000 | — | 31 Mar 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.8%
|
505,242
|
$14,833,905 | — | 31 Mar 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
1.8%
|
500,811
|
$14,703,811 | — | 31 Mar 2024 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.8%
|
497,000
|
$14,591,920 | — | 31 Mar 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
1.6%
|
435,573
|
$12,788,423 | — | 31 Mar 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1.5%
|
407,550
|
$11,965,668 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.4%
|
404,335
|
$11,871,276 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.4%
|
379,246
|
$11,134,663 | — | 31 Mar 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
1.2%
|
350,000
|
$10,276,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
319,787
|
$9,388,946 | — | 31 Mar 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
1%
|
289,943
|
$8,512,726 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.69%
|
193,422
|
$5,678,870 | — | 31 Mar 2024 | |
| Qiming U.S. Healthcare Fund II, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,519,648
|
$5,525,844 | — | 27 Jan 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.63%
|
176,417
|
$5,179,604 | — | 31 Mar 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.46%
|
129,211
|
$3,793,635 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
127,991
|
$3,759,210 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.4%
|
111,366
|
$3,269,706 | — | 31 Mar 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.39%
|
109,892
|
$3,226,429 | — | 31 Mar 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.37%
|
105,175
|
$3,087,939 | — | 31 Mar 2024 | |
| ROCHE HOLDING LTD |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,549,606
|
$2,950,874 | — | 25 Jan 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.28%
|
79,811
|
$2,343,249 | — | 31 Mar 2024 | |
| Mariner, LLC |
13F
|
Company |
0.19%
|
52,826
|
$1,550,971 | — | 31 Mar 2024 | |
| Amplitude Healthcare Holdings LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,300,000
|
$1,491,780 | — | 24 Sep 2021 | |
| Balaji Venkataraman |
3/4/5
|
FORMER DIRECTOR AND OFFICER |
—
class O/S missing
|
2,300,000
|
$1,491,780 | — | 24 Sep 2021 | |
| Howard I. Hoffen |
3/4/5
|
FORMER DIRECTOR |
—
class O/S missing
|
2,300,000
|
$1,491,780 | — | 24 Sep 2021 | |
| Kenneth F. Clifford |
3/4/5
|
FORMER OFFICER |
—
class O/S missing
|
2,300,000
|
$1,491,780 | — | 24 Sep 2021 | |
| Fernwood Investment Management, LLC |
13F
|
Company |
0.18%
|
49,470
|
$1,452,439 | — | 31 Mar 2024 | |
| LMR Partners LLP |
13F
|
Company |
0.16%
|
43,945
|
$1,290,225 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.15%
|
41,894
|
$1,230,008 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.14%
|
39,999
|
$1,174,371 | — | 31 Mar 2024 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
0.12%
|
35,000
|
$1,050,654 | — | 31 Mar 2024 | |
| Lion Point Capital, LP |
13F
|
Company |
0.11%
|
32,000
|
$939,520 | — | 31 Mar 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.25%
|
69,100
|
$811,925 | — | 31 Mar 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
23,324
|
$684,793 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.08%
|
23,271
|
$683,000 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
22,697
|
$666,384 | — | 31 Mar 2024 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.08%
|
21,525
|
$631,974 | — | 31 Mar 2024 | |
| Concurrent Investment Advisors, LLC |
13F
|
Company |
0.07%
|
20,409
|
$599,209 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.07%
|
20,357
|
$597,682 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
16,210
|
$475,926 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.05%
|
13,449
|
$394,863 | — | 31 Mar 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
—
class O/S missing
|
2,098,624
|
$381,949 | — | 31 Mar 2024 | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.04%
|
11,397
|
$334,616 | — | 31 Mar 2024 |
Institutional Holders of Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR) as of Q2 2024
As of 30 Jun 2024,
Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,557,013 shares.
The largest 10 holders included
Velan Capital Investment Management LP, Soleus Capital Management, L.P., Carlyle Group Inc., Qiming U.S. Ventures Management, LLC, Avidity Partners Management LP, FRANKLIN RESOURCES INC, BlackRock Inc., VANGUARD GROUP INC, Polar Capital Holdings Plc, and Samsara BioCapital, LLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
56
Q2 2024 holders
67
Holder diff
11
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.